Assessment of cardiac risk before non-cardiac general surgery

Heart

Volumn 92, Issue 12, 2006, Pages 1866-1872

  Schouten, Olaf ^a   Bax, Jeroen J ^b   Poldermans, Don ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DOBUTAMINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; MIVAZEROL;

CARDIOVASCULAR RISK; CLINICAL TRIAL; DOSE RESPONSE; ELECTIVE SURGERY; ELECTROCARDIOGRAPHY; GENERAL SURGERY; HEART INFARCTION; HEART SURGERY; HUMAN; LABORATORY TEST; MEDICAL ASSESSMENT; META ANALYSIS; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REVIEW; SCREENING TEST; SENSITIVITY AND SPECIFICITY; STRESS; SYSTEMATIC REVIEW;

ADRENERGIC BETA-ANTAGONISTS; DIAGNOSTIC IMAGING; ELECTROCARDIOGRAPHY; HEART DISEASES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; LABORATORY TECHNIQUES AND PROCEDURES; PREOPERATIVE CARE; REFERRAL AND CONSULTATION; RISK ASSESSMENT; RISK FACTORS; SURGICAL PROCEDURES, OPERATIVE;

EID: 33845229906     PISSN: 13556037     EISSN: None     Source Type: Journal    
DOI: 10.1136/hrt.2005.073627     Document Type: Review

References (29)

1. Boersma E, Kertai MD, Schouten O, et al. Perioperative cardiovascular mortality in noncardiac surgery: validation of the Lee cardiac risk index. Am J Med 2005;118:1134-41. ▶ Validation and improvement by adding surgical risk and age of the Lee risk index in a cohort of 108 593 patients undergoing non-cardiac surgery.
2. Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999;100:1043-9. ▶ Most widely used preoperative index for the prediction of cardiac risk, based on six clinical risk factors.
3. Goldman L, Caldera DL, Nussbaum SR, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Engl J Med 1977;297:845-50.
4. Ridley S. Cardiac scoring systems - what is their value? Anaesthesia 2003;58:985-91.
5. Detsky AS, Abrams HB, McLaughlin JR, et al. Predicting cardiac complications in patients undergoing non-cardiac surgery. J Gen Intern Med 1986;1:211-9.
6. Noordzij PG, Schreiner F, Galal W, et al. Prognostic value of preoperative electrocardiography in patients undergoing non-cardiac surgery. Circulation 2005;112:II-833.
7. Boersma E, Kertai MD, Bax JJ. A risk-model to assess perioperative cardiovascular mortality, developed in 108,593 patients undergoing non-cardiac surgery. Circulation 2003;108:652.
8. Yeh HM, Lau HP, Lin JM, et al. Preoperative plasma N-terminal pro-brain natriuretic peptide as a marker of cardiac risk in patients undergoing elective non-cardiac surgery. Br J Surg 2005;92:1041-5.
9. Feringa HH, Bax JJ, de Jonge RJ, et al. Plasma N-terminal pro-B-type natriuretic peptide for preoperative cardiac risk stratification in patients scheduled for major non-cardiac vascular surgery. Circulation 2005;112:II-362.
10. Sabatine MS, Morrow DA, de Lemos JA, et al. Acute changes in circulating natriuretic peptide levels in relation to myocardial ischemia. J Am Coll Cardiol 2004;44:1988-95.
11. Schreiner F, Bax JJ, Feringa HH, et al. Poor glycaemic control in diabetic patients prior to major vascular surgery is associated with an increased mortality. Circulation 2005;112:II-828.
12. Kertai MD, Boersma E, Bax JJ, et al. Comparison between serum creatinine and creatinine clearance for the prediction of postoperative mortality in patients undergoing major vascular surgery. Clin Nephrol 2003;59:17-23.
13. Kertai AAD, Bountioukos M, Boersma E, et al. Aortic stenosis: an underestimated risk factor for perioperative complications in patients undergoing noncardiac surgery. Am J Med 2004;116:8-13. ▶ This article addresses the impact of the presence and severity of aortic valve abnormalities in patients undergoing non-cardiac (vascular) surgery.
14. Eagle KA, Berger PB, Calkins H, et al. ACC/AHA guideline update for perioperative cardiovascular evaluation for noncardiac surgery - executive summary a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1996 Guidelines on Perioperative Cardiovascular Evaluation for Noncardiac Surgery). Circulation 2002;105:1257-67. ▶ Most recent ACC/AHA guidelines for perioperative cardiovascular evaluation in non-cardiac surgery. The ACC/AHA guidelines provide a framework for assessing cardiac risk in a variety of patients and surgical situations using a combination of evidence-based and authority-based approaches. The guidelines give an extensive overview of the literature.
15. Kertai MD, Boersma E, Bax JJ, et al. A meta-analysis comparing the prognostic accuracy of six diagnostic tests for predicting perioperative cardiac risk in patients undergoing major vascular surgery. Heart 2003;89:1327-34. ▶ Meta-analysis of the sensitivity and specificity of different types of preoperative non-invasive cardiac tests for predicting adverse perioperative cardiac events.
16. Mangano DT, Layug EL, Wallace A, et al. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. N Engl J Med 1996;335:1713-20. ▶ First large scale randomised study on the use of β blockers for the prevention of perioperative cardiac complications.
17. Poldermans D, Boersma E, Bax JJ, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. N Engl J Med 1999;341:1789-94. ▶ Randomised study in high-risk patients undergoing non-cardiac vascular surgery. This study shows an impressive improvement in cardiac outcome in high-risk patients on β blockers compared to patients not on β blockers.
18. Stevens RD, Burri H, Tramer MR. Pharmacologic myocardial protection in patients undergoing noncardiac surgery: a quantitative systematic review. Anesth Analg 2003;97:623-33.
19. Auerbach AD, Goldman L. Beta-blockers and reduction of cardiac events in noncardiac surgery: scientific review. JAMA 2002;287:1435-44.
20. Devereaux PJ, Beattie WS, Choi PT, et al. How strong is the evidence for the use of perioperative beta blockers in non-cardiac surgery? Systematic review and meta-analysis of randomised controlled trials. BMJ 2005;331:313-21.
21. Lindenauer PK, Pekow P, Wang K, et al. Perioperative beta-blocker therapy and mortality after major noncardiac surgery. N Engl J Med 2005;353:349-61.
22. Poldermans D, Bax JJ, Kertai MD, et al. Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation 2003;107:1848-51. ▶ First study describing the beneficial effects perioperative statin use in patients undergoing non-cardiac surgery.
23. Durazzo AE, Machado FS, Ikeoka DT, et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg 2004;39:967-75. ▶ First randomised double-blinded trial describing the beneficial effects perioperative statin use in patients undergoing non-cardiac surgery.
24. Lindenauer PK, Pekow P, Wang K, et al. Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery. JAMA 2004;291:2092-9.
25. O'Neil-Callahan K, Katsimaglis G, Tepper MR, et al. Statins decrease perioperative cardiac complications in patients undergoing noncardiac vascular surgery: the Statins for Risk Reduction in Surgery (StaRRS) study. J Am Coll Cardiol 2005;45:336-42.
26. Nishima K, Mikawa K, Uesugi T, et al. Efficacy of clonidine for prevention of perioperative myocardial ischemia: a critical appraisal and meta-analysis of the literature. Anesthesiology 2002;96:323-9.
27. Oliver MF, Goldman L, Julian DG, et al. Effect of mivazerol on perioperative cardiac complications during non-cardiac surgery in patients with coronary heart disease: the European Mivazerol Trial (EMIT). Anethesiology 1999;91:951-61.
28. Wijeysundera DN, Beattie WS. Calcium channel blockers for reducing cardiac morbidity after noncardiac surgery: a meta-analysis. Anesth Analg 2003;97:634-41.
29. McFalls EO, Ward HB, Moritz TE, et al. Coronary-artery revascularization before elective major vascular surgery. N Engl J Med 2004;351:2795-804. ▶ Large randomised trial evaluating the effect of preoperative cardiac revascularisation on postoperative outcome. This study showed no benefit for patients who underwent preoperative cardiac revascularisation (PCI or CABG) compared to patients without preoperative cardiac revascularisation.